Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The Fifth Region of Epidermal Growth Factor like-Domain of Thrombomodulin Is Essential to Produce Cytoprotection

Takayuki Ikezoe, MD PhD, Jing Yang, Chie Nishioka, Keigo Nakamura, Hiroya Yurimoto, Yasuyoshi Sakai, Goichi Honda, PhD, Akihito Yokoyama

Blood (2014) 124 (21): 4178.

https://doi.org/10.1182/blood.V124.21.4178.4178

Published: 2014

Journal Articles

STAT5A Regulates DNMT3 and Inactivates PTEN Tumor Suppressor Gene in CD34 + /CD38 − AML Cells

Asako Takeuchi, Chie Nishioka, Takayuki Ikezoe, Jing Yang, Akihito Yokoyama

Blood (2012) 120 (21): 4087.

https://doi.org/10.1182/blood.V120.21.4087.4087

Published: 2012

Journal Articles

CD82 Regulates STAT5/IL-10 and Supports Survival of Acute Myelogenous Leukemia Cells.

Chie Nishioka, Takayuki Ikezoe, Asako Takeuchi, Jing Yang, Akihito Yokoyama

Blood (2012) 120 (21): 2981.

https://doi.org/10.1182/blood.V120.21.2981.2981

Published: 2012

Journal Articles

CD34 + /CD38 − Acute Myelogenous Leukemia Cells Aberrantly Express Aurora Kinase A

Jing Yang, Takayuki Ikezoe, Mutsuo Furihata, Chie Nishioka, Akihito Yokoyama

Blood (2011) 118 (21): 1886.

https://doi.org/10.1182/blood.V118.21.1886.1886

Published: 2011

Journal Articles

Recombinant Human Soluble Thrombomodulin Enhances the Anti-Fibrinolytic and Anti-Leukemia Effects of All- Trans Retinoic Acid In Acute Promyelocytic Leukemia Cells.

Takayuki Ikezoe, Jing Yang, Chie Nishioka, Mayuka Isaka, Naomi Iwabu, Mizu Sakai, Ayuko Taniguchi, Kazuto Togitani, Goichi Honda, Akihito Yokoyama

Blood (2010) 116 (21): 1079.

https://doi.org/10.1182/blood.V116.21.1079.1079

Published: 2010

Journal Articles

CD34 + /CD38 - Leukemia Stem Cells Aberrantly Express CD82 Adhesion Molecule

Takayuki Ikezoe, Chie Nishioka, Jing Yang, Satoshi Serada, Tetsuji Naka, Akihito Yokoyama, Keiko Udaka

Blood (2010) 116 (21): 2168.

https://doi.org/10.1182/blood.V116.21.2168.2168

Published: 2010

Journal Articles

Inhibition of STAT5 by IL-1β or the Inhibitor of Janus Kinases Stimulates Dormant Human Leukemia Stem Cells and Sensitizes Them to Anti-Leukemia Agents.

Takayuki Ikezoe, Yang Jing, Chie Nishioka, Shinsuke Kojima, Asako Takeuchi, Akihito Yokoyama

Blood (2009) 114 (22): 1597.

https://doi.org/10.1182/blood.V114.22.1597.1597

Published: 2009

Journal Articles

Analysis of Aurora B Kinase in Non-Hodgkin’s Lymphoma.

Takayuki Ikezoe, Tamotsu Takeuchi, Chie Nishioka, Yoshihiro Adachi, Mutsuo Furihata, H. Phillip Koeffler, MD, Akihito Yokoyama

Blood (2008) 112 (11): 1610.

https://doi.org/10.1182/blood.V112.11.1610.1610

Published: 2008

Journal Articles

Blockade of mTOR Signaling Potentiates the Ability of Histone Deacetylase Inhibitor to Induce Growth Arrest and Differentiation of Acute Myelogenous Leukemia Cells.

Chie Nishioka, Takayuki Ikezoe, Yang Jing, H. Phillip Koeffler, MD, Akihito Yokoyama

Blood (2008) 112 (11): 1612.

https://doi.org/10.1182/blood.V112.11.1612.1612

Published: 2008

Journal Articles

Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo

Chie Nishioka, Takayuki Ikezoe, Jing Yang, Atsushi Miwa, Taizo Tasaka, Yoshio Kuwayama, Kazuto Togitani, H. Phillip Koeffler, Akihito Yokoyama

Blood (2008) 111 (10): 5086–5092.

https://doi.org/10.1182/blood-2007-06-098079

Published: 2008

Includes: Supplemental data

Journal Articles

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, Akihito Yokoyama

Blood (2007) 110 (6): 2034–2040.

https://doi.org/10.1182/blood-2007-02-073700

Published: 2007

Journal Articles

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Takayuki Ikezoe, MD, Chie Nishioka, Taizo Tasaka, MD, Ayuko Taniguchi, MD, Naoki Komatsu, MD, Yoshio Kuwayama, MD, Kazuto Togitani, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD

Blood (2006) 108 (11): 1990.

https://doi.org/10.1182/blood.V108.11.1990.1990

Published: 2006

NARROW

The Fifth Region of Epidermal Growth Factor like-Domain of Thrombomodulin Is Essential to Produce Cytoprotection

STAT5A Regulates DNMT3 and Inactivates PTEN Tumor Suppressor Gene in CD34 + /CD38 − AML Cells

CD82 Regulates STAT5/IL-10 and Supports Survival of Acute Myelogenous Leukemia Cells.

CD34 + /CD38 − Acute Myelogenous Leukemia Cells Aberrantly Express Aurora Kinase A

Recombinant Human Soluble Thrombomodulin Enhances the Anti-Fibrinolytic and Anti-Leukemia Effects of All- Trans Retinoic Acid In Acute Promyelocytic Leukemia Cells.

CD34 + /CD38 - Leukemia Stem Cells Aberrantly Express CD82 Adhesion Molecule

Inhibition of STAT5 by IL-1β or the Inhibitor of Janus Kinases Stimulates Dormant Human Leukemia Stem Cells and Sensitizes Them to Anti-Leukemia Agents.

Analysis of Aurora B Kinase in Non-Hodgkin’s Lymphoma.

Blockade of mTOR Signaling Potentiates the Ability of Histone Deacetylase Inhibitor to Induce Growth Arrest and Differentiation of Acute Myelogenous Leukemia Cells.

Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only